कंपनी का अवलोकन
Abrdn Healthcare Investors (HQH) operates as a closed-ended equity mutual fund that is launched and managed by abrdn Inc., focusing on public equity markets globally with a specific mandate to invest in the healthcare sector. This asset class spans biotechnology, medical devices, and pharmaceuticals, placing the entity squarely within the Financial Services sector and the Asset Management industry. The company demonstrates a market capitalization of $1.04B and generates annual revenue of $7.53M, while specific employee count data is not disclosed in the available records. These valuation and revenue figures indicate that the fund manages significant capital relative to its operational footprint, suggesting a mature structure typical of closed-end funds that seek to generate returns through stock selection in specialized verticals rather than through broad diversification or high headcount expansion.
वित्तीय स्वास्थ्य
The fund reports a trailing twelve-month revenue of $7.53M against a net income of $98.61M, while EBITDA data is not available in the current dataset. The substantial gap between the reported revenue and the significantly higher net income reveals an inverted cost structure where expenses are minimal or accounting adjustments result in a profit margin that exceeds the revenue base. Free cash flow figures are not reported, which prevents a direct assessment of operational cash generation but implies reliance on non-operational income sources or specific accounting treatments common in closed-end structures. The gross margin stands at 100.0%, indicating that the fund's investment activities do not incur direct costs of goods sold comparable to traditional asset management fee models. Conversely, the operating margin is negative at -88.1%, while the profit margin is anomalously high at 1309.0%, highlighting a complex relationship between operational expenses and net profitability driven by the fund's specific accounting methodology. The company holds cash of $59 and carries zero debt, resulting in a debt-to-equity ratio that is not applicable due to the absence of debt obligations. This balance sheet configuration suggests a conservative stance regarding leverage, although the lack of cash flow data limits the depth of liquidity analysis. The current ratio is 0.77, indicating that short-term assets are insufficient to cover short-term liabilities if liquidation occurs immediately, a common characteristic for certain closed-end fund structures. Return on Equity is 9.2%, whereas Return on Assets is -0.2%, revealing a disparity in how management effectiveness is measured against shareholder equity versus total asset utilization.
मूल्यांकन आकलन
The trailing twelve-month P/E ratio is 11.66, while the forward P/E is not available, making it impossible to compare the difference between them or infer an expected earnings trajectory based on analyst forecasts. The price-to-book ratio is 0.95, suggesting that the market values the company's equity slightly below its book value, which often occurs in asset-heavy or specialized investment vehicles. The price-to-sales ratio is 138.38, and EV/EBITDA is not available, indicating that traditional revenue-based valuation metrics are more relevant than earnings-based multiples for this specific instrument. The 52-week high is recorded at $20.46 and the low at $13.86, providing a defined trading range within which the asset has fluctuated over the past year. The beta value is 0.73, which signifies that the stock price exhibits lower volatility relative to the broader market, moving less aggressively than the S&P 500 during periods of market stress or rally.
Growth & Income
Revenue growth year-over-year is -48.7%, while earnings growth year-over-year is 91.1%, demonstrating that earnings are expanding at a rate vastly faster than revenue, a dynamic often seen in funds where fee structures or investment gains outpace revenue declines. The company offers a dividend yield of 13.4%, accompanied by a payout ratio of 139.1%, which indicates that the dividend payments exceed the reported net income. This high payout ratio relative to earnings suggests that the company is funding dividends through sources other than current operating profits, such as realized gains or accumulated cash reserves. Given the payout ratio exceeding 100%, the dividend sustainability depends heavily on the fund's ability to maintain high net income levels or access capital markets. Overall, the asset presents a profile of high current income yield paired with significant revenue contraction and a unique earnings expansion pattern that distinguishes it from traditional operating companies.
समकक्ष तुलना
Abrdn Healthcare Investors (HQH) संपत्ति प्रबंधन उद्योग में कार्यरत है। बाजार पूंजीकरण के आधार पर इसके निकटतम समकक्षों से तुलना इस प्रकार है:
संपत्ति प्रबंधन उद्योग का औसत P/E अनुपात 28.6x है। Abrdn Healthcare Investors का P/E अनुपात 12.0 है।